E Russo, A Spallarossa, B Tasso, C Villa, C Brullo - Pharmaceuticals, 2022 - mdpi.com
Retinoblastoma is a rare, sometimes hereditary, pediatric cancer. In high-income countries
this disease has a survival rate approaching 100%, while in low-and middle-income …